NCT06147960Recruiting
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Evaluation of the Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on the 24-month Recurrence Rate in Locally Advanced Cervical Cancer
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
Overexpression of inhibitors of apoptosis proteins (IAPs) in patients treated for locally advanced cervical cancer with exclusive radio-chemotherapy may have a prognostic role on the local recurrence rate at 24 months.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 13 Nov 2023
- Start date
- 26 Sept 2024
- Primary completion date
- May 2027
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Diseases
- Cervical cancer
- NCT number
- NCT06147960
What you commit to
- Study type: Observational
- Planned participants: 180
- From 26 Sept 2024 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients under court protection, guardianship or curatorship.
Who the study is looking for
- Patients treated with the exclusive radio-chemotherapy combination for locally advanced cervical carcinoma (stage Ib-IVb according to FIGO classification).
- Patients aged ≥ 18 years.
- Patients with a minimum of 2 years post-treatment follow-up.
- Patients for whom the initial biopsy specimen (before treatment) is available.
- Patients who have not indicated that they do not wish to participate in the study.
- Patients affiliated to or benefiting from a health insurance scheme.
Age in the registry: 18 years to - · Sex: Female
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Nîmes Coordinator of this site? Confirm its status | Nîmes | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.